Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best SS-31 Supplier: Synthesis Method Comparison

Choosing the best SS-31 supplier requires understanding how synthesis method impacts final product quality. Not all solid-phase peptide synthesis (SPPS) is equivalent. Automation level, resin type, and quality control checkpoints create measurable differences

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Choosing the best SS-31 supplier requires understanding how synthesis method impacts final product quality. Not all solid-phase peptide synthesis (SPPS) is equivalent. Automation level, resin type, and quality control checkpoints create measurable differences in sequence fidelity and purity.
  • | Synthesis Method | Purity Range | Sequence Accuracy | Dimethyltyrosine Incorporation | Scalability | Best Use Case | Professional Assessment ||—|—|—|—|—|—|| Fully Automated SPPS (No Custom AA Library) | 85–92% | Moderate. Prone to substitution errors | Not supported. Tyrosine used instead | High. 100+ mg batches | Cost-sensitive applications where exact sequence is not critical | Avoid for SS-31. Dimethyltyrosine cannot be incorporated, producing non-functional analogs || Semi-Automated SPPS (Manual Custom AA Addition) | 94–97% | High. Manual verification at critical steps | Supported with verified coupling efficiency | Moderate. 10–50 mg batches | Research applications requiring verified sequence with moderate throughput | Standard for most commercial SS-31 suppliers. Adequate if batch testing is rigorous || Small-Batch Manual SPPS (Real Peptides Standard) | 97–99.5% | Very high. Each coupling monitored by Kaiser test or TNBS assay | Fully supported with post-synthesis MS confirmati
  • The bottom line: for SS-31 specifically, small-batch manual synthesis with verified dimethyltyrosine incorporation is the only method that consistently delivers research-grade peptide. Automated synthesis cannot accommodate unnatural amino acids without custom configuration, and contract manufacturers introduce supply-chain opacity that makes tracing synthesis errors nearly impossible. Real Peptides uses small-batch synthesis with exact amino-acid sequencing for every mitochondrial research peptide, ensuring that what arrives in your lab matches what was ordered at the molecular level.